<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: tuberculosis bacterium</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Wolf in sheep's clothing: Uncovering how deadly bacteria trick immune system</title>
   	 <description>An outbreak of tuberculosis in the skid row area of downtown Los Angeles may have exposed up to 4,500 individuals to the bacterium that causes the deadly disease and has left federal officials scrambling to intervene.</description>
     <link>http://medicalxpress.com/news/2013-02-wolf-sheep-uncovering-deadly-bacteria.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 28 Feb 2013 14:00:04 EST</pubDate>
	 <guid isPermaLink="false">news281280867</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/wolfinsheeps.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists reveal how natural antibiotic kills tuberculosis bacterium</title>
   	 <description>A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works. This promising drug candidate is active against many of the drug-resistant types of the tuberculosis bacterium that no longer respond to treatment with the front-line drug isoniazid.</description>
     <link>http://medicalxpress.com/news/2012-09-scientists-reveal-natural-antibiotic-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 17 Sep 2012 09:30:13 EST</pubDate>
	 <guid isPermaLink="false">news267093003</guid>
	 
</item>
<item>
     <title>Tuberculosis vaccine being tested in Phase II trial</title>
   	 <description>The only tuberculosis vaccine currently available is already over 90 years old - and is unsatisfactory in terms of its effectiveness. Although it protects young children against developing tuberculosis, it quickly loses its effectiveness and does not protect young people and adults against the infection. Scientists from the Max Planck Institute for Infection Biology in Berlin have now developed an improved vaccine which has been undergoing clinical trials on humans since 2008. The safety and tolerability of the vaccine candidate is being tested in a Phase II trial on infants in South Africa. The results of the preceding Phase I trial have already shown that the vaccine candidate fulfils the relevant safety requirements and that its mechanism of action works.</description>
     <link>http://medicalxpress.com/news/2012-03-tuberculosis-vaccine-phase-ii-trial.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 26 Mar 2012 07:58:58 EST</pubDate>
	 <guid isPermaLink="false">news251967524</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/tuberculosis.jpg" width="90" height="90" />
</item>


</channel>
</rss>
